# FDA Inspection 1131026 - Curexa - East, LLC dba Curexa - October 09, 2020

Source: https://www.keypedia.com/records/fda_inspections/curexa-east-llc-dba-curexa/ced5a67b-dfd1-439d-9700-7267f8becf47
Source feed: FDA_Inspections

> FDA Inspection 1131026 for Curexa - East, LLC dba Curexa on October 09, 2020. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1131026
- Company Name: Curexa - East, LLC dba Curexa
- Inspection Date: 2020-10-09
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1304370 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/curexa-east-llc-dba-curexa/0e60ce51-4eee-4101-b2d6-2ce356d77e23)
- [FDA Inspection 1304370 - 2026-03-05](https://www.keypedia.com/records/fda_inspections/curexa-east-llc-dba-curexa/7f0cf623-d43c-4ba2-8a69-47c1618b7d11)
- [FDA Inspection 1179459 - 2022-09-09](https://www.keypedia.com/records/fda_inspections/curexa-east-llc-dba-curexa/57d11900-d0aa-4800-9094-05e15385602f)
- [FDA Inspection 1068498 - 2018-08-31](https://www.keypedia.com/records/fda_inspections/curexa-east-llc-dba-curexa/94995ac8-ca86-485a-a9d2-b8c7d2c4231d)

Company: https://www.keypedia.com/companies/curexa-east-llc-dba-curexa/0497cfad-c674-4485-9b11-13ede03b0cfd

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c